slides · global inventory
Solution
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 8,880
Current window 5,611-5,640
Pages 296
Rows per page 30
Slide type
5,611-5,640 of 8,880
25
Includes a schematic of the SARS-CoV-2 genome and protein structure, alongside specific drug development strategies.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
26
The slide uses a three-pillar framework to summarize the drug's value proposition.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
07
The slide uses a layered arrow diagram to represent the technology stack (ProModel, Observe DaaS, Dominate).Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Solution1 hit
08
The slide uses a horizontal arrow-based layout to categorize offerings.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Solution1 hit
09
The slide highlights two core product offerings and lists key capabilities and representative customers (L3Harris and US Navy).Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Solution1 hit
23
The slide uses a process-flow visual to connect capabilities to specific solutions and products.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
06
The slide uses a visual comparison between healthy cells (alkaline) and cancer cells (acidic) to demonstrate the selective binding mechanism.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
07
The slide uses a three-column layout to categorize the platform's application, each with a corresponding antibody diagram.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
38
The slide uses a before-after-bridge style comparison between the problem (toxicity) and the solution (BA3182).BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
06
Uses a before-after-bridge framework to contrast current pain points with the proposed solution.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
The slide uses a two-column layout to contrast the hardware platform with the consumable cartridges.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
The chart shows a dose-response curve where longer incubation times (48+ hours) result in higher efficacy (lower cell viability) at lower concentrations compared to 24 hours.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
27
Includes a detailed biological pathway diagram showing mitochondrial and membrane-level interactions.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
28
Includes citations to Chi et al. (2017) and Piccardo et al. (2019).Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
31
Includes molecular structure and protein target visualizations.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
34
Includes an in vitro cell viability dose-response curve and a pharmacokinetic (PK) model showing plasma concentration over time.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
38
The slide uses a visual comparison of tumor burden in mice to demonstrate efficacy.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
15
The slide uses a process-oriented layout mapping strategic pillars to specific outcomes/metrics.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank Beat · Solution1 hit
07
Dare Bioscience | Investor Presentation Deck | 26 slidesDare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Beat · Solution1 hit
09
The slide uses a yellow underline to emphasize the lack of FDA-approved treatments.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide serves as a transition or focus slide for the company's lead product.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
05
Uses an analogy framework to explain the product's value proposition by mapping enterprise tech categories to Doximity's core features.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
07
Doximity | Investor Presentation Deck | 18 slidesDoximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
05
The slide uses a visual metaphor of donor vs patient cells to explain the mechanism of action.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
16
The diagram uses a callout-style list to map specific cellular functions to a central dendritic cell illustration.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution1 hit
17
The slide uses a circular process flow to represent the manufacturing cycle of a personalized cell therapy.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution1 hit
21
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
23
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
25
The slide uses a process flow diagram to explain the therapeutic intervention.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
28
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit